|
Aug 7
|
Janux Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
|
|
Aug 7
|
Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating
|
|
Aug 7
|
Why Merck (MRK) is a Top Value Stock for the Long-Term
|
|
Aug 7
|
United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation
|
|
Aug 7
|
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
|
|
Aug 7
|
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
|
|
Aug 7
|
Germany’s Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales
|
|
Aug 6
|
Halozyme Therapeutics Guidance Upgrade Driven by Robust Royalty Revenue, Morgan Stanley Says
|
|
Aug 6
|
Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline
|
|
Aug 6
|
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
|
|
Aug 6
|
PBM reform was dropped from Trump’s spending bill. It could have saved billions.
|
|
Aug 5
|
Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck
|
|
Aug 5
|
Zoetis Inc. (ZTS): A Bull Case Theory
|
|
Aug 5
|
Cabometyx Sales Miss Mark in Q2: What Does This Mean for EXEL Stock?
|
|
Aug 5
|
Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alfa in Head and Neck Cancer with CPS <1
|
|
Aug 5
|
Residual DNA Testing Global Market Forecast to 2030 | Novel Modalities, Emerging Markets Growth, Continuous Processing Integration, and Rising CRO/CDMO Outsourcing
|
|
Aug 5
|
Cancer Vaccine Research Report 2025-2035 | Market Accelerates with Key Players Like Merck and Moderna, Backed by Pharma-Biotech Collaborations and Academic Partnerships
|
|
Aug 5
|
Let’s make a deal? Big Pharma execs express varying views on their M&A future
|
|
Aug 4
|
Merck (MRK) Collaborates On Virtual Tumor Models To Advance Cancer Research
|
|
Aug 4
|
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
|